16:42 EST Perspective Therapeutics files $200M mixed securities shelf
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CATX:
- Perspective completes initial dose escalation cohort for targeted alpha therapy
- Perspective Therapeutics initiated with a Buy at JonesResearch
- Perspective Therapeutics Reports Third Quarter Fiscal 2023 Results and Recent Business Highlights
- Perspective announces first patient dosed in Phase 1/2a study of VMT-a-NET
- Perspective completes recruitment for first patient cohort in VMT01 trial